Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis. - Wikidata - wikimedia - TriplyDB

Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis.

Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis.

http://www.wikidata.org/entity/Q34378203

about

Differential protein expression profiles of cyst fluid from papillary thyroid carcinoma and benign thyroid lesions Tea consumption didn’t modify the risk of fracture: a dose–response meta-analysis of observational studies Quantitative assessment of the association between MHTFR C677T (rs1801133, Ala222Val) polymorphism and susceptibility to bladder cancer The Potential Diagnostic Utility of TROP-2 in Thyroid Neoplasms.Meta-analyses between 18 candidate genetic markers and overweight/obesity Imp3 expression in benign and malignant thyroid tumors and hyperplastic nodules The Profile of Heparanase Expression Distinguishes Differentiated Thyroid Carcinoma from Benign Neoplasms.The expression and significance of Gal-3 and MUC1 in colorectal cancer and colon cancer.A Pilot Study of Galectin-3, HBME-1, and p27 Triple Immunostaining Pattern for Diagnosis of Indeterminate Thyroid Nodules in Cytology With Correlation to Histology.Does tea consumption correlate to risk of fracture? A meta-analysis.Role of Core Needle Biopsy in the Management of Atypia/Follicular Lesion of Undetermined Significance Thyroid Nodules: Comparison with Repeat Fine-Needle Aspiration in Subcategory Nodules.Systematic reviews of diagnostic tests in endocrinology: an audit of methods, reporting, and performance.Pulmonary metastasis of a papillary thyroid carcinoma and primary lung adenocarcinoma: two coincident carcinomas at the same location.The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis The significance of caspase-cleaved cytokeratin 18 in pleural effusion Cruciferous vegetables consumption and the risk of ovarian cancer: a meta-analysis of observational studies Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue.Correlations Between Hector Battifora Mesothelial-1 (HBME-1) Expression and Clinical Pathological Characteristics and Prognosis of Osteosarcoma Patients.Glycophenotyping of osteoarthritic cartilage and chondrocytes by RT-qPCR, mass spectrometry, histochemistry with plant/human lectins and lectin localization with a glycoprotein The association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects.Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: a meta-analysis.Update on the molecular diagnosis and targeted therapy of thyroid cancer.Imaging, genetic testing, and biomarker assessment of follicular cell-derived thyroid cancer.Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.Proteome analysis in thyroid pathology.The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis.Impact of Gravity on Thyroid Cells.Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology.Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer.Galectin-1 is a diagnostic marker involved in thyroid cancer progression.The Intraoperative Immunohistochemical Staining of CD56 and CK19 Improves Surgical Decision for Thyroid Follicular Lesions.How microgravity changes galectin-3 in thyroid follicles.High-resolution proteomics and metabolomics in thyroid cancer: Deciphering novel biomarkers.Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives.Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.Runt-Related Transcription Factor 2 (Runx2) Is Responsible for Galectin-3 Overexpression in Human Thyroid Carcinoma.Galectin-3 and HBME-1 Expression on Agarose Cell Blocks from Fine-needle aspirates of Follicular Cell-derived Thyroid Tumors.Monoclonal antibody HBME-1 reacts with a minor subset of B cells with villous surface and can be useful in the diagnosis of hairy cell leukemia and other indolent lymphoproliferations of villous B lymphocytes.CXC motif ligand 12 as a novel diagnostic marker for papillary thyroid carcinoma.CIP2A is a poor prognostic factor and can be a diagnostic marker in papillary thyroid carcinoma.

P2860

Q21090550-67D572D0-A71B-450B-A04B-37B4BF25348F Q27498887-9A70B9A0-0CA7-41D6-8C56-BD5FE1B935A1 Q28387679-1F24D7CC-FDE8-48C2-96A1-48F7D242A973 Q30488923-AF0C7E25-D6F8-4148-ABFA-BB1D96FE500A Q33559160-39DD0AA9-B588-48B4-86EF-7C04B4309672 Q35125481-9E836B91-C16A-4AEB-8376-BBD598397CFF Q35815927-F1E49EBB-1792-40EA-AA39-B0C0D1252601 Q35915348-F6DD6573-8E4D-49B0-B77E-1056DBC8D9DA Q35933836-640CBF08-10B2-429C-B48C-A38CF91F970C Q35959119-1C5644EB-ADA0-40AE-95A7-2DA70088B9DB Q36262243-8FD30D39-13BC-4B21-8863-FA27C2BA7119 Q36393699-F5A0FA6E-AEBB-4D30-AC7F-5D219A8C0D1E Q36688991-A8A7F7F3-5A81-4916-B4A2-2F218C3B2B9B Q37096860-1F71A318-D79C-4A27-B121-0B508D8ABAB1 Q37575189-CE250922-539B-406D-B9B2-9F1DFFE5742A Q37607818-440C54A8-7887-4DFD-9838-005BC2461407 Q37620932-78069890-1DB9-401B-9A9F-920D6C99BE8B Q37643254-F8005890-3557-4590-B83F-8AB3718B2420 Q37690232-3D243F68-8A1C-4827-8523-2DF6DCC7E882 Q38121659-B7C2BB74-4415-4125-A0AC-C6DF95967925 Q38157110-E4912C27-453D-4E17-9222-B70C2FEB2B0B Q38208701-F0B0CA90-497F-4EBB-AE7B-2AF4C316C816 Q38225580-51648625-815F-483D-B128-EE9475C62F1C Q38388372-0B06FECB-EF69-4D95-9FAC-AE1485395061 Q38541463-6E04BE91-A8A6-4C12-B8AC-21FE025B57F2 Q38665279-FD9081F3-C3D6-4F05-9FED-1EBB9969A613 Q39283124-00FF0AD7-86D7-48B1-A50B-251522681870 Q39284246-54D87348-5F9B-4822-A62D-4BC47DE08A83 Q41387787-B5EB9E1D-FFA2-4AB0-A6E0-223CB73F7B60 Q41470048-7FE557C1-E56C-4206-B25E-1AFFD66D9A14 Q41686062-EB0D75FF-E8F7-4578-A05E-A6E25A5719C7 Q41906428-411F2EA2-5CAF-449C-A47A-35562ECCB394 Q47287949-BF7FB70A-C81F-4E52-94A4-C838F157AA94 Q47696912-6551B493-1FAF-4F0F-8851-7ED6F1DAC996 Q48159180-9D33A4C6-C05D-44F8-85B1-A7020D45398D Q48301345-38698806-C994-44FD-8E45-6637A7B1638A Q49163563-63CFC361-D525-4055-90B5-869762F62E19 Q50485167-891C150A-EC46-405E-96CB-D6DE15907966 Q50893020-B5D1DB55-BCED-47C5-8FE5-F70A4749C53F Q51158345-11E71751-66FD-4E6B-8A48-D7EB076D7D6F

P2860

Expression of CK-19, galectin-3 and HBME-1 in the differentiation of thyroid lesions: systematic review and diagnostic meta-analysis.

http://www.wikidata.org/entity/Q34378203

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Expression of CK-19, galectin- ...... and diagnostic meta-analysis.

@ast

Expression of CK-19, galectin- ...... and diagnostic meta-analysis.

@en

Expression of CK-19, galectin- ...... and diagnostic meta-analysis.

@nl

type

label

Expression of CK-19, galectin- ...... and diagnostic meta-analysis.

@ast

Expression of CK-19, galectin- ...... and diagnostic meta-analysis.

@en

Expression of CK-19, galectin- ...... and diagnostic meta-analysis.

@nl

prefLabel

Expression of CK-19, galectin- ...... and diagnostic meta-analysis.

@ast

Expression of CK-19, galectin- ...... and diagnostic meta-analysis.

@en

Expression of CK-19, galectin- ...... and diagnostic meta-analysis.

@nl

P1433

Q34378203-FF1AA310-9116-44A3-A75D-DFCB4F93D421

P1476

Q34378203-BFC75DD7-86CF-4710-907D-889550E4DAF5

P2093

Q34378203-35436969-EB2B-4BBD-BE75-60C4613E6CE0

Q34378203-67C86484-E6CC-4319-B5C9-47331F536910

Q34378203-863C2DED-9F7D-4BDC-921A-A7D69B65EF21

Q34378203-9F9970CA-AF0F-4510-8098-65B5A71BAE28

Q34378203-A3B4AEB8-83EF-46AE-AC84-E1EB4A4CCAB6

Q34378203-B4C7BEA2-F1FD-406A-8934-C6F45223B0B6

P275

Q34378203-41B9FD6D-F04C-40E4-8C64-946A49230E7A

P2860

Q34378203-06C33F66-7E48-4792-A07D-F45ECC8BCD26

Q34378203-0B4A78F5-055C-46D9-91AE-53ED9966E7EF

Q34378203-10AD97E3-A584-4D0D-B929-7EFA29F0CB43

Q34378203-1110A9CC-F93E-4096-B46B-399C9B705457

Q34378203-13003DA3-89A4-480F-BAEF-36DA0F00B228

Q34378203-144EF804-6982-49C4-9BE7-4FFE3BD5348E

Q34378203-16FEE343-A0B7-4E16-840F-83C3F52C1ACA

Q34378203-283B9B28-2EE8-4490-9348-FD1004E28AA7

Q34378203-2A83A3B1-4624-4948-A909-D5D1B3ADADF1

Q34378203-32942782-98EC-42D1-A0DC-6A84A850BF71

P2888

Q34378203-6652AC00-B2A9-4168-A9D8-47D82DBBDFE1

P304

Q34378203-70175546-CCBD-4808-A142-0294584C2E8E

P31

Q34378203-443da04b-db2e-4630-a499-db76728eb43e

Q34378203-9667B09B-2E5D-4F9B-9D7B-F72B312D21D4

Q34378203-A3A65C00-E243-4F99-8DBA-1F00544ED8E8

P356

Q34378203-A71F5F36-6694-499F-897D-BC287DFE2271

P478

Q34378203-169B85CB-A99D-4CA8-9EC2-C3F169390034

P5008

Q34378203-44392C58-17BA-4D73-A780-9E88D92AC567

P577

Q34378203-26CD4718-5635-4769-90C6-9C6639E997EA

P5875

Q34378203-50F8FA35-BBD8-4910-9EF9-53D131276E22

P6179

Q34378203-4F79AE79-1267-4AC2-AE59-9C0E4D035ED8

P698

Q34378203-58A246CD-905B-4F25-BC39-A325D3DED9A8

P921

Q34378203-233596FE-1A15-4CD2-945E-BE2D523E3241

Q34378203-61B2E9A8-7644-4908-A1E8-A708E448F983

Q34378203-7CF5B551-1C74-492A-8E56-FEF392DF8147

Q34378203-8315948D-9A0E-49FF-B97B-52613D0E8C27

Q34378203-92E15B1D-149B-45DC-A05A-55AF3B22A8E2

Q34378203-96B670F2-F685-436D-BC15-D192E9DF0860

Q34378203-A1EE8E3D-071E-4912-B862-AA7CC7270416

Q34378203-E761DA6D-D6E0-4FB6-82C8-E11DC3CF2952

Q34378203-F120A605-3248-418C-941B-A7BC57CFF903

P932

Q34378203-B6C7C82E-103F-46B2-89E8-8B0BE68391E9

P356

P1433

Diagnostic Pathology

P1476

Expression of CK-19, galectin- ...... and diagnostic meta-analysis.

@en

P2093

Adriana Braz Del Giglio

http://www.w3.org/2001/XMLSchema#string

Auro Del Giglio

http://www.w3.org/2001/XMLSchema#string

Carolina Ogawa Matsubayashi

http://www.w3.org/2001/XMLSchema#string

Leandro Luongo de Matos

http://www.w3.org/2001/XMLSchema#string

Maria Aparecida da Silva Pinhal

http://www.w3.org/2001/XMLSchema#string

Michelle de Lima Farah

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.

Cancer statistics, 2010

Meta-DiSc: a software for meta-analysis of test accuracy data.

The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas.

Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.

Cytokeratin subtypes in thyroid tumours: immunohistochemical study with emphasis on the follicular variant of papillary carcinoma.

Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China.

Follicular neoplasms of the thyroid: view, biases, and experiences.

Follicular thyroid lesions, elements that affect both diagnosis and prognosis.

Genetic alterations in a primary medullary thyroid carcinoma and its lymph node metastasis in a patient with 15 years follow-up.

P2888

P304

97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1746-1596-7-97

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2012-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230664560

http://www.w3.org/2001/XMLSchema#string

P6179

1050491282

http://www.w3.org/2001/XMLSchema#string

P698

22888980

http://www.w3.org/2001/XMLSchema#string

P921

endocrine system

fibrous protein

tumor biomarkers

cytoskeletal proteins

thyroid gland disease

macromolecular substances

P932

3523001

http://www.w3.org/2001/XMLSchema#string